CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.
June 27th 2022
The FDA approval of Breyanzi, a CAR-T cell therapy, offers patients with relapsed/refractory lymphoma the opportunity for long-term remission, and hope for a cure, one expert said.
June 24th 2022
From Robin Roberts’ personal message about her partner, Amber Laign’s cancer, to a dancing group inspired by an “America’s Got Talent” contestant who died of cancer, here’s what is happening in the cancer space this week.
May 31st 2022
Kymriah, a CAR-T cell therapy, was approved by the Food and Drug Administration for the treatment of patients with pretreated, relapsed/refractory follicular lymphoma.
May 24th 2022
Losing my hair due to cancer treatment was mentally and physically painful, but I learned a few tips and tricks along the way.
May 19th 2022
When you put your feelings out there in cancer support groups — be it in-person or virtual — you’re opening your ideas up to others’ interpretation, and some might not like what you have to say.
May 17th 2022
Watching my sister undergo cancer treatment made me want to become a nurse, though after she was re-diagnosed, I’ve had to step away from that career path.
May 10th 2022
I can’t stand the “battle language” of cancer, including terms like “cancer warrior” and “losing the battle” with the disease.
May 6th 2022
From “Leave It to Beaver” actor Tony Dow revealing his cancer diagnosis to a woman faking a cancer diagnosis to collect $100,000 in donations and a European soccer star finishing treatment, here’s what’s happening in the cancer space this week.
May 5th 2022
After my sister was re-diagnosed with stage 4 cancer, I was reminded to find laughter in every day because nobody knows what tomorrow holds.
April 26th 2022
The majority of patients with relapsed/refractory large B-cell lymphoma were alive between four and five years after being treated with axi-cel.
April 25th 2022
A panel of experts on the FDA’s Oncologic Drugs Advisory Committee voted that all future approvals of PI3K inhibitors to treat blood cancer be backed by randomized clinical trial data.
April 20th 2022
Findings from an early-phase clinical trial show that treatment with epcoritamab led to a 63.1% response rate in patients with pretreated large B-cell lymphoma.
April 19th 2022
After going public with my cancer diagnosis, I was met with an onslaught of “grief tourists” who may not have been interested in the harsh realities of cancer.
April 13th 2022
After surviving cancer, I’ve developed complex post-traumatic stress disorder, which comes with feelings of insecurity and anger.
April 5th 2022
The plan is to assess the safety and efficacy of the genetically engineered cell therapy alongside high-dose chemotherapy and blood stem cell transplantation in approximately 150 patients with lymphoma.
April 4th 2022
The FDA’s decision to approve Yescarta in patients with large B-cell lymphoma that has failed to respond to first-line treatment is based on data that showed that the use of the CAR-T cell therapy resulted in a significant increase in patients who were alive at two years compared with the standard-of-care second-line treatment.
March 23rd 2022
My survivor friends and I share the insensitive comments we have received about our cancer diagnosis.
March 14th 2022
Unlike stem cell transplant, which has strict eligibility criteria, the majority of patients with blood cancer may be able to receive CAR-T cell therapy, regardless of other comorbidities, explained an expert.
March 10th 2022
After seeing my brother go through extraordinary pain because of lymphoma and then surviving breast cancer myself, I always pushed through the pain — even when I shouldn’t have.
February 28th 2022
There are now more drugs than ever to treat and prevent graft-versus-host disease in patients with blood cancer who receive a stem cell transplant.
February 17th 2022
The Food and Drug Administration will review data on Breyanzi (lisocabtagene maraleucel) — a CAR-T cell therapy — for use in the second-line setting for patients with relapsed or refractory large B-cell lymphoma to determine if the indication will be granted approval.
February 14th 2022
Supportive care should be implemented promptly after patients receive CAR-T cell therapy, but as one expert notes, patients with cancer are often referred for this care too late.
January 24th 2022
A survivor of multiple cancers explains how “visits” from deceased friends and loved ones made her feel safe before undergoing treatments.
January 21st 2022
A woman explains how she grapples with the acceptance that her sister may never enter remission from cancer.
January 20th 2022
Recent study results showed that the use of a remote monitoring device worn on the upper arm may help patients with blood cancers seek assistance for serious complications while receiving intensive treatments.
January 14th 2022
CAR-T cell therapy with Yescarta in patients with relapsed/refractory large B-cell lymphoma had improved responses to treatment and survival in the second-line setting, which may help save more lives than standard care, an expert said.
January 11th 2022
The National Comprehensive Cancer Network now recommends prophylactic monoclonal antibodies for immunosuppressed individuals, such as certain patients with cancer.
January 10th 2022
A phase 2 trial was recently launched to examine the safety and efficacy of oral inhibitor VK-2019 in patients with advanced Epstein-Barr Virus-positive nasopharyngeal carcinoma, a rare type of head and neck cancer, and lymphoma.
December 28th 2021
2021 was full of research advancements and FDA drug approvals that continue to improve cancer care for patients with a variety of malignancies.